- Galena Biopharma Inc GALE shares surged 40.6 percent to $2.76. Galena is currently evaluating its GALE-401 therapy for the treatment of thrombocythemia. The company confirmed the regulatory pathway to advance its therapy into a pivotal, Phase 3 trial.
- Dataram Corp DRAM shares jumped 24 percent to $2.37. Dataram shares have dropped 16.23 percent over the past 52 weeks, while the S&P 500 index has gained 10.33 percent in the same period.
- Micronet Enertec Technologies Inc MICT climbed 22.2 percent to $1.43 after the company disclosed that its subsidiary has received a $1,060,000 continuous purchase order for its recently released TREQr5 product.
- Live Ventures Inc LIVE shares jumped 20.5 percent to $31.45 following release of earnings report and strong guidance. Live Ventures reported FY16 earnings of $8.92 per share on revenue of $79 million.
- Ocera Therapeutics Inc OCRX shares gained 18.2 percent to $2.60. H.C. Wainwright initiated coverage on Ocera Therapeutics with a Buy rating and a $10 price target.
- Cellect Biotechnology Ltd. - American Depositary Shares APOP shares surged 15 percent to $3.22.
- Dorian LPG Ltd LPG shares gained 11.6 percent to $9.06.
- Porter Bancorp, Inc. PBIB shares rose 11.4 percent to $12.99.
- Signal Genetics Inc SGNL shares rose 9.6 percent to $5.16. Signal Genetics shares have jumped 563.38 percent over the past 52 weeks, while the S&P 500 index has gained 10.33 percent in the same period.
- CareDx Inc CDNA shares climbed 9.4 percent to $2.90.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsIntraday UpdateMarketsMoversInformation TechnologyInternet Software & ServicesTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
